The IMPPP study looks at how the use of a new computer tool can help pharmacists and GPs to work together to improve the use of medicines in patients with polypharmacy.  The study provides a way to systematically identify patients whose prescribing may put them at risk.  We are asking practices to recruit 50 of these patients and if your practice is randomised to the intervention arm, to provide them with a four-stage medication review. The review comprises: - a pharmacist medical record review (10 min per patient), an interprofessional discussion between the GP and pharmacist (10 min per patient), a review with the patient which can be conducted remotely (20 min per patient) and where clinically indicated, patient follow up.  Full training in the use of the software and the medication review process will be provided, including wider issues pertinent to the care of patients with polypharmacy outside of the trial.  Study set up and software installation will take place remotely and will commence in July, ready to invite patients to participate during August-September 2021.  Medication review delivery will commence September 2021 for a period of 6 months.

We need to recruit 27 practices in the South West and 27 practices in the West Midlands areas.

Practice recruitment is now open and if you are interested and meet the following criteria, please sign up for one of our information session held online via TEAMS.

Criteria:

• Practice uses EMIS
• List size of over 6000 patients
• Preferably has a Practice Pharmacist as part of the clinical team, but this is not essential.

The study team are running online information events comprising a 15-minute overview of the trial followed by 30-minutes for questions.  If you would like to find out more, please contact imppp-study@bristol.ac.uk for session dates.